drugset / Trial / NCT05387759
A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to assess the effects of aticaprant on QT/ QT interval corrected for heart rate (HR) (QTc) intervals and electrocardiogram (ECG) morphology at therapeutic and supratherapeutic exposures in healthy adult participants.
Timeline
- Start
- 2022-05-30
- Primary completion
- 2022-10-04
- Completion
- 2022-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aticaprant | Small molecule | — | Oral |
| Subject | Moxifloxacin | Small molecule | — | Oral |
Indications
No indication recorded.